2021, 2020, 2019, 2018, 2017, 2016, 2015, 2014, 2013
January – June · Revenues amounted to MSEK 1 965.3 (1 460.9), corresponding to an increase of +35% for the period.· The organic growth1 during the period was +6%. The currency impact was +3% while the acquisitions of the Sylphar Group and E45® brand portfolio from Reckitt generated growth of +26%.· EBIT (Operating Profit) amounted...
Today, on 12 April 2022, Karo Pharma is publishing its annual report for 2021 on the company’s website, www.karopharma.com. For further information, please contact: Lisa Westerdahl, Head of Corporate Communication, 073-329 70 04, lisa.westerdahl@karopharma.com Jon Johnsson, CFO, 073-507 88 61, jon.johnsson@karopharma.com The Annual Report is published in Swedish and English. The Swedish version represents the...
Q4, October – December · Revenues amounted to MSEK 762.0 (721.2), corresponding to an increase of +6% for the period.· The organic growth1 during the fourth quarter was +9%. The currency impact in the quarter was 1% while the acquisitions adjusted for the divestments generated a net effect of -5%.· EBIT (Operating Profit) amounted to...
